Get startedLog in
    Picture of Cambium Bio logo

    CMB — Cambium Bio Income Statement

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Cambium Bio, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

    2021
    June 30th
    2022
    June 30th
    2023
    June 30th
    2024
    June 30th
    2025
    June 30th
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue7.07000.1290.67
    Cost of Revenue
    Gross Profit———0.080.469
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses4.544.211.352.374.83
    Operating Profit2.52-4.21-1.35-2.24-4.16
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes2.76-4.31-1.69-2.26-3.84
    Provision for Income Taxes
    Net Income After Taxes2.76-4.31-1.69-2.26-3.84
    Net Income Before Extraordinary Items
    Net Income2.76-4.31-1.69-2.26-3.84
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income2.76-4.31-1.69-2.26-3.84
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS0.918-1.35-0.508-0.145-0.21
    Dividends per Share